The 2026 ARDD Meeting in Boston will feature a dedicated government and regulatory panel led by senior FDA officials and ARPA-H representatives. The panel will explore how clinical trials of emerging therapeutics can be aligned with regulatory mandates and the evidence required to advance new interventions responsibly.
George Church, a renowned expert in genomics and aging research, will present at the 13th ARDD Meeting in Boston. He will discuss advancements in gene therapy, cellular reprogramming, and other emerging technologies that hold promise for addressing age-related decline.
The 13th Aging Research & Drug Discovery Meeting will take place in Boston, bringing together academia, pharmaceutical companies, and investors to accelerate the translation of aging research into practical R&D and therapeutic programs. The event features visionary presenters, including Christophe Weber, former CEO of Takeda, and is su...
The 13th Aging Research & Drug Discovery (ARDD) Meeting will take place from October 1–3, 2026, at Harvard University's David Rubenstein Treehouse. Adiv Johnson, Ph.D., chief scientific officer at Tally Health, is one of the featured speakers.
Kan Chen, Ph.D., will present at the 13th Aging Research & Drug Discovery Meeting in Boston, bringing together top minds in aging research to accelerate the development of interventions that extend healthy lifespan. The conference is anchored by top sponsors and will focus on translating scientific discoveries into medicines.
The 13th Aging Research & Drug Discovery Meeting will bring together top researchers, clinicians, and industry leaders to accelerate the development of interventions that extend healthy lifespan. The conference will focus on translating scientific discoveries into medicines, with a strong emphasis on collaboration and innovation.
The 13th Aging Research & Drug Discovery (ARDD) Meeting will take place in Boston, featuring Jim Flynn's presentation. The event aims to accelerate the development of interventions that extend healthy lifespan by bringing together leading minds in aging research.
The 13th Aging Research & Drug Discovery (ARDD) Meeting will take place in Boston, featuring visionary presenters and leaders from top pharmaceutical companies. The conference aims to accelerate the development of interventions extending healthy lifespan.
The 13th Aging Research & Drug Discovery (ARDD) Meeting will be held in Boston, featuring talks from top experts like Alejandro Aguayo-Orozco. The event aims to accelerate the translation of aging research into practical R dD and therapeutic programs.
The 13th Aging Research & Drug Discovery (ARDD) Meeting will connect academic researchers, clinical investigators, and pharmaceutical companies in Boston. Carl Gordon's presentation highlights the translation of longevity science into real-world medicine.
Jacqueline C.K. Lam, Ph.D., Chief Operating Officer of ElohaX Ltd., will be a featured speaker at the 13th Aging Research & Drug Discovery (ARDD) Meeting in Boston. The conference brings together leading minds in aging research and pharmaceutical companies to accelerate the development of interventions that extend healthy lifespan.
The 13th Aging Research & Drug Discovery (ARDD) Meeting will bring together leaders from top pharmaceutical companies, researchers, and investors to accelerate the development of interventions that extend healthy lifespan.
The 13th Aging Research & Drug Discovery (ARDD) meeting will take place in Boston, bringing together leaders from top pharmaceutical companies and academic researchers to advance longevity science. Ruth Gimeno's presentation is part of this effort to translate fundamental discoveries into interventions improving healthspan.
The 13th ARDD meeting will bring together experts from academia, pharmaceutical companies, and investors to accelerate the development of interventions extending healthy lifespan. The conference aims to translate fundamental discoveries into practical R&D and therapeutic programs.
The 13th Aging Research & Drug Discovery (ARDD) meeting will take place in Boston from October 1-3, featuring visionary speakers like Thomas Marron of Eli Lilly. The conference aims to accelerate the translation of breakthroughs in aging research into practical R&D and therapeutic programs.